Analyst Ratings for Repligen Corp. (RGEN)

Updated: 2017-07-27

Shares of Repligen Corp. (NASDAQ:RGEN) have received a consensus rating of Overweight from Wall Street analysts. RGEN had previously received a consensus rating of Overweight a month ago.

A buy rating was issued by 4 analysts, 0 issued an overweight rating, 2 issued a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Several price targets were given for RGEN by the analysts covering the stock. The most optimistic analyst gave a price target of 50, implying potential capital gains of 22.79 percent. The most pessimistic price target was 40, implying potential capital losses of -1.77 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -11.76 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.82 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, which can be compared to the 0 analysts that decreased their estimates. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 2 analysts made negative revisions to their fiscal year's estimates.

RGEN has an estimated earnings growth rate of 43.7 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Wall Street investors typically prefer a PEG ratio to be smaller than 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of RGEN is 2.45.

RGEN has a 52-week high of 46.81 and a 52-week low of 26.16. The current market price is above the trailing year's low by 55.66 percent, and 13.01 percent lower than its 52-week high. RGEN has a P/E ratio of 107.16. Investors typically compare the P/E ratio to a company's peers in the industry. The RGEN value stock report compares RGEN to some of its peers using value stock charts. The market cap of RGEN is $1.54 billion. RGEN is estimated to release their earnings results for the quarter on 0000-00-00, days from today.